Cytarabine and disease progression Patient Reports February 11, 2012
Cytarabine Side Effects Report #5088342-0
Cytarabine side effect was reported by a Physician from UNITED STATES on Aug 11, 2006. Male patient, 51 years of age, was diagnosed with leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, hepatic failure, oxygen saturation decreased, pleural effusion. Cytarabine dosage: unknown. Patient was hospitalized. Patient died on 07/27/2006.
Cytarabine Side Effects Report #5117994-1
Cytarabine side effect was reported by a Physician from UNITED STATES on Sept 21, 2006. Male patient, 51 years of age, was diagnosed with leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, hepatic failure, pleural effusion. Cytarabine dosage: unknown. Patient was hospitalized. Patient died on 07/27/2006.
Cytarabine Side Effects Report #5150815-X
Cytarabine side effect was reported by a Physician from FRANCE on Oct 25, 2006. Male patient, 28 years of age, weighting 97.00 lb, was diagnosed with condition aggravated, nervous system disorder and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, facial palsy, nervous system disorder, pain
, rales. Cytarabine dosage: 50 MG; QOW; INTH. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5102103-5
Cytarabine side effect was reported by a Physician from UNITED STATES on Aug 28, 2006. Female patient, 60 years of age, was diagnosed with chronic lymphocytic leukaemia refractory and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: asthenia, disease progression, nausea
. Cytarabine dosage: 1000MG/M2/IV. Patient was hospitalized. Patient died on 06/21/2006.Cytarabine Side Effects Report #5286926-8
Cytarabine side effect was reported by a Health Professional from AUSTRALIA on Mar 23, 2007. Female patient, 82 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: decreased appetite, diarrhoea, disease progression, hypotension, lethargy, malaise, pallor, skin turgor decreased. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. Patient was hospitalized. Patient died on 02/23/2007.
Cytarabine Side Effects Report #5472552-4
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Female patient, 82 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, decreased appetite, diarrhoea, disease progression, fatigue, hypotension, lethargy, malaise, skin turgor decreased. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with GLYCOPYRROLATE, MAXOLON, PHOSPHATE, ATORVASTATIN CALCIUM, PANADEINE CO, ALLOPURINOL, AMIODARONE HYDROCHLORIDE, BETAGAN. Patient was hospitalized. Patient died on 02/23/2007.
Cytarabine Side Effects Report #5268680-9
Cytarabine side effect was reported by a Health Professional from CANADA on Mar 05, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: agitation, anaemia, disease progression, dyspnoea, platelet count decreased, restlessness, stomatitis, white blood cell count decreased. Cytarabine dosage: 36 MG PER_CYCLE SC. During the same period patient was treated with TRANSEXAMIC ACID, RANITIDINE, ALTACE, TEMAZEPAM, COVERSYL, GARASONE, TYLENOL, LIPITOR. Patient was hospitalized. Patient died.
Cytarabine Side Effects Report #5285398-7
Cytarabine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression. Cytarabine dosage: 20 MG/M2 PER_CYCLE IV. Patient died.
Cytarabine Side Effects Report #5299690-3
Cytarabine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, sepsis
. Cytarabine dosage: 20 MG/M2 PER_CYCLE IV. Patient died.Cytarabine Side Effects Report #5299690-3
Cytarabine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, sepsis
. Cytarabine dosage: 20 MG/M2 PER_CYCLE IV. Patient died.Cytarabine Side Effects Report #5470330-3
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, febrile bone marrow aplasia, febrile neutropenia, hepatic candidiasis, hepatic lesion, liver abscess, sepsis
. Cytarabine dosage: 20 MG/M2 PER_CYCLE IV. Patient was hospitalized. Patient died on 01/02/2006.Cytarabine Side Effects Report #5235051-0
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2007. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood culture positive, blood pressure decreased, culture urine positive, disease progression, enterobacter infection, neutropenia, no therapeutic response, sepsis
. Cytarabine dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, FLECAINIDE ACETATE, DIGOXIN, CALCIUM CITRATE WITH VITAMIN D, DEXAMETHASONE, VALACYCLOVIR, TYLENOL, CEFEPIME. Patient was hospitalized. Patient died on 07/13/2006.Cytarabine Side Effects Report #5271378-4
Cytarabine side effect was reported by a Health Professional from SERBIA AND MONTENEGRO on Mar 05, 2007. Female patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, disease progression, leukocytosis, lung infection, pneumonia
. Cytarabine dosage: 20 MG/M2 QD SC. During the same period patient was treated with ACYCLOVIR, CIPROFLOXACIN. Patient was hospitalized. Patient died on 02/09/2007.Cytarabine Side Effects Report #4909136-X
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2006. Female patient, 73 years of age, weighting 138.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, haemodialysis, hypotension, renal failure acute. Cytarabine dosage: 10 MG/M2 BID SC. During the same period patient was treated with ARSENIC TRIOXIDE, LANSOPRAZOLE, LOPERAMIDE, LOMOTIL, LEVALBUTEROL HYDROCHLORIDE, MEROPENEM, DOCUSATE, SENNA. Patient was hospitalized. Patient died on 12/22/2005.
Cytarabine Side Effects Report #5235130-8
Cytarabine side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 24, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: culture positive, disease progression, empyema, haematocrit decreased, haemoglobin decreased, haemothorax, klebsiella infection, pneumonia
, refusal of treatment by patient. Cytarabine dosage: 20 MG/M2 DAILY SC. During the same period patient was treated with ACETAMINOPHEN, FENTANYL, MAGNESIUM OXIDE, DIGOXIN. Patient recovered.Cytarabine Side Effects Report #5284437-7
Cytarabine side effect was reported by a Health Professional from CANADA on Mar 14, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. Patient died on 09/30/2006.
Cytarabine Side Effects Report #5268579-8
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal erosion, haemoglobin decreased, haemorrhage, neutrophil count decreased, platelet count decreased, poisoning
, septic shock. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with CIPROFLOXACIN, BISEPTOL, ORUNGAL, FORTUM, VANCOMYCIN, METROGYL. Patient died on 10/26/2006.Cytarabine Side Effects Report #5394811-6
Cytarabine side effect was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood culture positive, catheter sepsis, disease progression, escherichia infection, gastrointestinal erosion, haemorrhage, septic shock. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with CIPROFLOXACIN, BISEPTOL, ORUNGAL, FORTUM, VANCOMYCIN, METROGYL. Patient died on 10/26/2006.
Cytarabine Side Effects Report #4663253-0
Cytarabine side effect was reported by a Consumer or non-health professional from on Mar 18, 2005. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: confusional state, coordination abnormal, disease progression, dyspnoea, febrile neutropenia, hypotension, respiratory distress, septic shock, urinary incontinence
. Cytarabine dosage: 100 MG/M2 DAILY IV. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5286038-3
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 67 years of age, weighting 207.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, disease progression, haemoglobin decreased, subarachnoid haemorrhage, thrombocytopenia, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE. Patient died on 01/10/2007.
Cytarabine Side Effects Report #5592555-9
Cytarabine side effect was reported by a Consumer or non-health professional from POLAND on Jan 02, 2008. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bronchopneumonia, disease progression, gastric ulcer, hepatic failure, loss of consciousness, pulmonary oedema, respiratory failure, shock. Cytarabine dosage: 200 MG IV. During the same period patient was treated with FLUCONAZOLE, CEFAZEDONE, OMEPRAZOLE, DECITABINE, ADRIAMYCIN PFS, PEFLOXACIN, KETOCONAZOLE. Patient was hospitalized. Patient died on 11/10/2006.
Cytarabine Side Effects Report #5844622-X
Cytarabine side effect was reported by a Health Professional from POLAND on July 17, 2008. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, disease progression, endoscopy abnormal, erythema, hypokalaemia, hyponatraemia. Cytarabine dosage: 35.62 MG OTH SC. During the same period patient was treated with TERLIPRESSIN, DEXAMETHASONE, OMEPRAZOLE, POTASSIUM CHLORIDE, ETAMSYLATE, SUCRALFATE, CALCIUM. Patient was hospitalized. Patient died on 06/05/2007.
Cytarabine Side Effects Report #4783584-3
Cytarabine side effect was reported by a Consumer or non-health professional from GREECE on Sept 13, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: cough, disease progression, lung infiltration, lung injury, rales, respiratory failure, thrombocytopenia, white blood cell count increased. Cytarabine dosage: 400 MG/M2 IV. Patient died.
Cytarabine Side Effects Report #5231596-8
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Jan 26, 2007. Female patient, 53 years of age, weighting 184.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: cardiomegaly, disease progression, dyspnoea, ejection fraction decreased, transaminases increased, ventricular failure. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE, ZOFRAN, SINGULAIR, ATROVENT, ADVAIR DISKUS, WELLBUTRIN. Patient was hospitalized. Patient died on 06/25/2006.
Cytarabine Side Effects Report #5852571-6
Cytarabine side effect was reported by a Physician from UNITED STATES on Aug 07, 2008. Female patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: abdominal distension, activities of daily living impaired, ataxia
, disease progression, dysphagia, hypophagia, impaired gastric emptying, neurotoxicity. Cytarabine dosage: 100MG/M2/DAY/IV FOR 7 DAYS; 3G/M2/IV/12 HO. Patient was hospitalized. Patient died.Cytarabine Side Effects Report #5430445-2
Cytarabine side effect was reported by a Health Professional from POLAND on Aug 14, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: anaemia, bronchopneumonia, disease progression, gastroenteritis
, neutropenia, thrombocytopenia. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with ETAMSILATE, TRANEXAMIC ACID, ATORVASTATIN, PERINDOPRIL ERBUMINE, OMEPRAZOLE, CODEINE PHOSPHATE, AMINOPHYLLINE, AMIKACIN. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #4636955-X
Cytarabine side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: adenoviral hepatitis, adenovirus infection, ascites, coagulopathy, diarrhoea, disease progression, enterocolitis haemorrhagic, febrile neutropenia, gastritis. Cytarabine dosage: 75 MG/M2. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, ASPARAGINASE, CYCLOPHOSPHAMIDE. Patient died.
Cytarabine Side Effects Report #4819859-9
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 21, 2005. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: adenovirus infection, coagulopathy, diarrhoea, disease progression, enterocolitis haemorrhagic, febrile neutropenia, gastritis. Cytarabine dosage: 75 MG/M2 DAILY. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, METHOTREXATE, ASPARAGINASE, CYCLOPHOSPHAMIDE. Patient died.
Cytarabine Side Effects Report #5292075-5
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient, weighting 349.4 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: disease progression. Cytarabine dosage: 1260 MG; 180 MG IV OVER 24 HRS X 7 DAYS. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5376393-8
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2007. Female patient, weighting 209.9 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acidosis, apnoea, bacterial sepsis, cardiac arrest
, cellulitis
, disease progression, hypotension, pain
, pancytopenia. Cytarabine dosage: unknown. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5940255-5
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2008. Male patient, weighting 42.77 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: agitation, cardio-respiratory arrest, confusional state, disease progression, escherichia infection, hepatomegaly, neutropenia, respiratory rate increased, septic shock. Cytarabine dosage: 70 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #6018904-5
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2008. Male patient, weighting 42.77 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, agitation, blood pressure decreased, cardio-respiratory arrest, confusional state, disease progression, heart rate increased, hepatomegaly, respiratory rate increased. Cytarabine dosage: 70 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.
Cytarabine and disease progression 